(2-methylphenyl) (E)-3-(4-methoxyphenyl)prop-2-enoate

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (2-methylphenyl) (E)-3-(4-methoxyphenyl)prop-2-enoate
• 化学式: C₁₇H₁₆O₃
• 分子量: 268.31
• InChiKey: CUELUTFXCGRJNN-FMIVXFBMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• ULTRAVIOLET ABSORBER
  申请人：Lead Chemical Co., Ltd.

  公开号：EP2192106B1

  公开（公告）日：2012-02-29
• MIXTURES OF COSMETIC UV ABSORBERS
  申请人：BASF SE

  公开号：EP3128993B1

  公开（公告）日：2020-08-26
• AGENTS CONTAINING LARGE QUANTITIES OF UV STABILIZERS
  申请人：BASF SE

  公开号：US20160067158A1

  公开（公告）日：2016-03-10

  The invention relates to highly concentrated agents for the preparation of sunscreen final formulations, comprising (a) 15 to 50 wt. % of oily substance, (b) 4 to 30 wt. % of anionic surfactant, (c) 0.5 to 25 wt. % of further co-surfactant which differs from (b), (d) 25 to 75 wt. % of UV filter, and (e) optionally water and/or auxiliary substances to 100 wt. %. and its use for the preparation of sunscreen final formulations and the preparation thereof.
• SUNSCREEN FORMULATIONS OPTIMIZED FOR THE FORMATION OF VITAMIN D
  申请人：BASF SE

  公开号：US20180200170A1

  公开（公告）日：2018-07-19

  The present invention relates to a sunscreen formulation comprising at least one of the UV filters (A) selected from (a) triazine derivatives; (b) cinnamic acid derivatives; (c) bis-resorcinyl triazines; (f) benzimidazole derivatives; (is) 4-Methylbenzylidene Camphor; (h) benzoyl piperazine derivatives; (j) benzoxazole derivatives; (k) diarylbutadiene derivatives; (I) phenyl benzotriazole derivatives; (n) benzylidene malonates; (o 3 ) TEA-Salicylate; (r) imidazoline derivatives; (u) inorganic UV filters selected from metal oxides; (v) naphthalates; and (w) merocyanine derivatives; and optionally comprising at least one of the UV filters (B) selected from (d) aminobenzophenone derivatives; (e) dibenzoylmethane derivatives; (g) β,β-Diphenylacrylate derivatives; (i 5 ) camphor derivatives different from; (o 3 ) salicylate derivatives different from; (p) anthranilate derivatives; and (s) benzalmalonate derivatives; wherein the ratio R of the effective irradiance for previtamin D 3 formation E pvd to the effective irradiance for erythema formation E er on the skin is at least 1.8, for increasing the transmittance of UV radiation on human skin for the production of cholecalciferol (previtamin D 3 ) and simultaneously for the use in a method for protecting the human skin against UV radiation when exposed to the sun, which method comprises applying said sunscreen formulation to the skin.
• US8252273B2
  申请人：——

  公开号：US8252273B2

  公开（公告）日：2012-08-28